A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

Nearly five years ago, Crispr-Cas9 made headlines with its ability to edit genes — finding, removing, and even replacing genetic material. The technology has guided researchers toward new drugs, foods ...

In a step toward treating mitochondrial diseases, researchers in the Netherlands have successfully edited harmful mutations in mitochondrial DNA using a genetic tool known as a base editor. The ...